Northwest Gynecological Cancer Symposium
Friday, September 8, 2023
8:30 AM – 6:30 PM
The Rivkin Center is proud to present the third biennial Northwest Gynecological Cancer Symposium (NGCS) to be held on Friday, September 8, 2023 from 8:30am to 6:30pm at the University of Washington, South Lake Union Campus in Seattle, Washington.
NGCS is designed to facilitate communication and foster collaboration between scientists in the Pacific Northwest working on the prevention, early detection, and treatment of gynecological cancers.
Jessica McAlpine, MD
University of British Columbia/Vancouver Coastal Health
Elizabeth Swisher, MD
University of Washington/Fred Hutchinson Cancer Center
Sanjay Malhotra, PhD, FRSC
Oregon Health & Science University/Knight Cancer Institute
Accepting Abstracts for Poster Presentation
Researchers (faculty, postdocs/fellows, staff scientists, graduate students, etc) based in Washingtion, Oregon, and British Colombia are invited to submit abstracts on original work for consideration for poster presentation. Work must pertain to gynecological cancer-related research areas listed below. Abstract length should not exceed 3,000 characters, including spaces.
Abstracts may be submitted on basic science, preclinical, clinical and public health projects on gynecological research, including the following research areas:
Animal models, biomarkers, cancer stem cells, cell biology, chemoresistance, clinical research, DNA repair, early detection, epigenetics, etiology/pathophysiology, genetics, genomics, health and healthcare disparities, immunology, molecular mechanisms, novel therapies, prevention, proteomics/metabolomics, survivorship, tumor microenvironment, and other topics relevant to gynecological cancer research.
The poster abstract submission deadline is 11:59pm, Monday, August 28, 2023.
Share this event
Download the NGCS flyer to share with colleagues or post on message boards.
Registration is FREE but you must register to partake in the catered lunch and reception. Registration is limited to 120 participants. Registration closes on September 1, 2023.
Check out the 2019 NGCS program and event details.
Parking is available at UW SLU garages. The entrances to both garages are on Republican St. Hourly and daily rates are offered (payment by Visa/Mastercard only). Parking for four or more hours costs $21. For UW employees, parking in the SLU garages is free if you have a UW parking pass. Garage parking is free to all after 3:30pm. Please note that you cannot ENTER the garage after 5:30pm, but you can exit at any time.
The garage elevator will take you directly to the lobby with the reception desk.
NOTE: You will need to pay for your parking at the pay kiosk in the lobby to leave the garage. The arm at the exit will not raise without a paid/validated ticket.
Transportation within Seattle
The “One Bus Away” app provides real time arrival information for buses, the link light rail, and the streetcar. Each bus stop should also have a poster indicating approximate arrival times for each route.
Fare is $2.75 and exact change is required upon boarding. Ask your driver for a transfer ticket, which allows the use of King County Metro bus lines for the next two hours. Learn more about fares here.
South Lake Union Streetcar
The streetcar runs between the Fred Hutchinson Cancer Research Center and downtown Seattle at 10 to 15 minute intervals. Fare is $2.25 and pay stations are located at every streetcar stop and accept credit cards or coins. See hours here.
Ride Share & Taxi’s
Uber and Lyft are very popular in Seattle. Alternatively, traditional taxi services are available as well.
Registration is FREE but you must register to partake in catered lunch and reception. Online registration closes September 1. Registration is limited to 120 participants.
8:00am – 8:30am
Check-in & Poster Setup
8:30am – 8:40am
Opening Remarks by Dr. Jackie Lang, Rivkin Center
SESSION I: EMERGING THERAPEUTICS
Tanja Pejovic, MD, PhD Oregon Health & Science University, Knight Cancer Institute
8:40am – 9:25am
Designing drugs to overcome treatment resistance
Sanjay Malhotra, PhD, FRSC Oregon Health & Science University, Knight Cancer Institute
9:25am – 9:40am
Complete loss of SWI/SNF chromatin remodeling activities elicits a targetable metabolic shift in ovarian cancer
Yemin Wang, PhD, University of British Columbia
9:40am – 9:55am
Nanoparticle-mediated follistatin mRNA Delivery: A potential therapeutic strategy for metastatic ovarian cancer and cancer-associated cachexia
Tetiana Korzun, Oregon Health & Science University
9:55am – 10:10am
Defective STING signaling in low-grade serous ovarian cancer: An opportunity for oncolytic viruses therapy
Dawn Cochrane, PhD, University of British Columbia
10:10am – 10:45am
SESSION II: TUMOR MICROENVIRONMENT
Jackie Lang, PhD Rivkin Center
10:45am – 11:00am
Precision medicine opportunities: Uniformity across stromal components of ovarian cancer histotype contrasts heterogeneous disease
Karolin Heinze, PhD, University of British Columbia
11:00am – 11:15am
Changes in the tumor microenvironment marks transition from serous borderline tumor to low grade serous carcinoma
Rodrigo Vallejos, University of British Columbia
11:15am – 11:45am
Poster Presentation Lightning Round
11:45am – 12:45pm
SESSION III: DEEP DIVE INTO ENDOMETRIAL CANCER
Yvette Drew, MD, PhD, University of British Columbia, BC Cancer Vancouver
12:45pm – 1:30pm
Advances in endometrial cancer; towards precision oncology
Jessica McAlpine, MD, University of British Columbia, Vancouver Coastal Health
1:30pm – 1:45pm
p53 abnormal endometrial carcinomas copy number signatures by shallow whole genome sequencing
Juliana Sobral de Barros, MSc, BC Cancer Agency
1:45pm – 2:00pm
Assessing the reproducibility crisis in vaginal microbiome studies for clinical applications in endometrial cancer
Dollina Dodani, University of British Columbia
2:00pm – 2:40pm
SESSION IV: ETIOLOGY, PATHOLOGY, & DETECTION
John Liao, MD, PhD, University of Washington
2:40pm – 3:25pm
Two decades of PARP inhibitors: Lessons learned for precision treatment of ovarian cancer
Elizabeth Swisher, MD, University of Washington, Fred Hutchinson Cancer Center
3:25pm – 3:40pm
Importance of genetic testing in rare ovarian carcinomas: lynch syndrome and endometrioid ovarian carcinoma
Andrea Neilson, MD, University of British Columbia
3:40pm – 3:55pm
Modeling the formation of SCCOHT with SMARCA4-mutant ovarian cells and SWI/SNF inhibitors
Adam Krieg, PhD, Oregon Health & Science University
3:55pm – 4:00pm
4:00pm – 5:00pm
5:00pm – 6:30pm
eSense-Cancer: Patient engagement as a strategy for adapting an online sexual health tool for gynecologic cancer survivors
Genevieve Allaire-Stacey | University of British Columbia
Outpatient Screening for Early-Stage High-Grade Serous Ovarian Cancer using Endoscopic Optical Coherence Tomography
John Black, PhD | Glannaventa, Inc.
Persistent sociodemographic disparities in the type of permanent contraceptive procedure performed at Cesarean delivery
Ann Cathcart, MD, PhD | Oregon Health & Science University
Characterizing somatic TP53 mutations in non-cancerous and high-risk fallopian tubes using ultra-deep sequencing
CoohleenAnn Coombes, MSc | University of Washington
Targeting metabolic reprogramming in ARID 1 A/B dual-deficient dedifferentiated endometrial cancinoma
Rebecca Ho | University of British Columbia/BC Cancer Research Institute
Multi-omics analysis to predict Paclitaxel-treated response and novel therapeutic targets in ovarian cancer
Boyoung Jeong, PhD | Knight Cancer Institute, Oregon Health & Science University
Modeling the development of Clear Cell Ovarian Carcinoma (CCOC) using culture and single cell RNA sequencing
Forouh Kalantari | BC Cancer Research Center
DMBA-induced ovarian carcinoma: a clinically characterized model for OncoTherad® immunotherapy and anticancer therapies
Bianca Ribeiro de Souza, PhD | University of British Columbia, Institute of Biology – University of Campinas
TP53 mutational landscape in non-cancerous endometrium during the lifespan of Black and White individuals
Eric Rios-Doria, MD, MS | University of Washington
The Rivkin Center gratefully acknowledges our sponsor for the 2023 Northwest Gynecological Cancer Symposium. Their vital support and dedication helps make this event possible. Thank you!
For more information about sponsoring the 2023 NW Gynecological Cancer Symposium, please contact Halie Steward, Donor Relations & Events Manager, at email@example.com or (206) 584-2010. To learn more, download the Sponsor Benefits Package.
Available activity sponsorships:
- Lunch Sponsor – SOLD
- Reception Sponsor
- Coffee & Tea Sponsor – SOLD
Coffee & Tea Sponsor
NGCS Planning Committee
John Liao, MD, PhD
University of Washington
Tanja Pejovic, MD, PhD
Oregon Health & Science University, Knight Cancer Institute
Yvette Drew, MD, PhD
University of British Columbia,
BC Cancer Vancouver
Jackie Lang, PhD